home / stock / cyth / cyth quote
Last: | $0.70 |
---|---|
Change Percent: | -1.03% |
Open: | $0.687 |
Close: | $0.70 |
High: | $0.7 |
Low: | $0.6465 |
Volume: | 35,265 |
Last Trade Date Time: | 03/21/2025 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.7 | $0.687 | $0.7 | $0.7 | $0.6465 | 35,265 | 03-21-2025 |
$0.68 | $0.64 | $0.68 | $0.688 | $0.6221 | 26,905 | 03-20-2025 |
$0.6695 | $0.64 | $0.6695 | $0.6784 | $0.64 | 38,516 | 03-19-2025 |
$0.65 | $0.6412 | $0.65 | $0.6656 | $0.616 | 65,087 | 03-18-2025 |
$0.661 | $0.7 | $0.661 | $0.73 | $0.64 | 78,794 | 03-17-2025 |
$0.7 | $0.7583 | $0.7 | $0.7583 | $0.6909 | 33,639 | 03-14-2025 |
$0.7 | $0.6603 | $0.7 | $0.729 | $0.6602 | 28,208 | 03-13-2025 |
$0.6736 | $0.71 | $0.6736 | $0.72 | $0.6736 | 29,467 | 03-12-2025 |
$0.677 | $0.7 | $0.677 | $0.75 | $0.677 | 19,607 | 03-11-2025 |
$0.701 | $0.73 | $0.701 | $0.7583 | $0.7006 | 65,689 | 03-10-2025 |
$0.736 | $0.7621 | $0.736 | $0.79 | $0.73 | 15,989 | 03-07-2025 |
$0.752 | $0.71 | $0.752 | $0.7929 | $0.71 | 135,865 | 03-06-2025 |
$0.7128 | $0.71 | $0.7128 | $0.76 | $0.7001 | 32,294 | 03-05-2025 |
$0.7125 | $0.7285 | $0.7125 | $0.7327 | $0.701 | 43,163 | 03-04-2025 |
$0.751 | $0.741 | $0.751 | $0.8 | $0.701 | 194,296 | 03-03-2025 |
$0.7599 | $0.747 | $0.7599 | $0.77 | $0.7301 | 46,810 | 02-28-2025 |
$0.770099 | $0.730101 | $0.770099 | $0.78 | $0.730101 | 98,715 | 02-27-2025 |
$0.769 | $0.75 | $0.769 | $0.7836 | $0.73 | 59,660 | 02-26-2025 |
$0.761 | $0.81 | $0.761 | $0.822 | $0.7501 | 75,979 | 02-25-2025 |
$0.8019 | $0.89 | $0.8019 | $0.9098 | $0.8019 | 101,024 | 02-24-2025 |
News, Short Squeeze, Breakout and More Instantly...
Cyclo Therapeutics Inc. Company Name:
CYTH Stock Symbol:
NASDAQ Market:
-1.03% G/L:
$0.70 Last:
35,265 Volume:
$0.687 Open:
$0.70 Close:
Cyclo Therapeutics Inc. Website:
Eyenovia Inc. (EYEN) is expected to report $-8 for Q4 2024 Nemaura Medical Inc. (NMRD) is expected to report for quarter end 2024-12-31 LanzaTech Global Inc. (LNZA) is expected to report $-0.16 for Q4 2024 Investcorp Credit Management BDC Inc. (ICMB) is expected to report for Q2 2025 ...
The planned merger with Cyclo Therapeutics is anticipated to close in Q3 pending shareholder approvals Post-merger the Company intends to focus its efforts on Cyclo’s lead clinical program Trappsol ® Cyclo™ NEWARK, N.J., March 13, 2025 (GLOBE NEWSW...
2025-02-07 09:23:14 ET DENVER, Colo., Feb 07, 2025 ( 247marketnews.com )- Cyclo Therapeutics (NASDAQ: CYTH ) reportedly made significant progress in its ongoing Phase 3 TransportNPC study. The study is evaluating Trappsol Cyclo for the treatment of Niemann-Pick Disease Type C1 (NPC1...